Letter: Entecavir versus tenofovir on serum lipoprotein levels of hepatitis B virus-related hepatocellular carcinoma after curative hepatectomy-Author's reply

被引：0
|
作者：
Ogawa, Eiichi [1 ,2 ]
机构：
[1] Kyushu Univ Hosp, Dept Gen Internal Med, Fukuoka, Japan
[2] Kyushu Univ Hosp, Dept Gen Internal Med, 3-1-1 Maidashi,Higashi Ku, Fukuoka 8128582, Japan
来源：
ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2023年 / 58卷 / 08期
关键词：
D O I：
10.1111/apt.17693
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
LINKED CONTENT This article is linked to Ogawa et al papers. To view these articles, visit and
引用
收藏
页码：845 / 846
页数：2
相关论文
共 50 条
  • [41] Entecavir versus tenofovir on the recurrence of hepatitis B virus related hepatocellular carcinoma after liver transplantation: a Korean nation-wide study
    Kim, D. -G.
    Min, E. -K.
    Yim, S. H.
    Choi, M. C.
    Koh, H. -H.
    Kang, M.
    Lee, J. G.
    Kim, M. S.
    Joo, D. J.
    Lee, J.
    TRANSPLANTATION, 2023, 107 (09) : 265 - 265
  • [42] Impact of Nucleoside Analog Entecavir on Survival of Patients With Hepatitis B Virus-Related Hepatocellular Carcinoma
    Komorizono, Yasuji
    Sako, Katsumi
    Nakaya, Mari
    Shibatou, Toshihiko
    GASTROENTEROLOGY, 2012, 142 (05) : S916 - S916
  • [43] The Risk of Hepatocellular Carcinoma in Entecavir Versus Tenofovir Treated US Cohort With Chronic Hepatitis B Virus
    Kramer, Jennifer R.
    Richardson, Peter A.
    Kim, Hyunseok
    Hsu, Yao-Chun
    Kanwal, Fasiha
    El-Serag, Hashem B.
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (04) : 1111 - 1113
  • [44] Letter: treatment of HBeAg plus chronic hepatitis B - is tenofovir truly superior to entecavir? Author's reply
    Gao, L.
    Trinh, H. N.
    Li, J.
    Nguyen, M. H.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2014, 39 (11) : 1339 - 1340
  • [45] Antiviral Therapy and Hepatitis B Virus-Related Hepatocellular Carcinoma Recurrence Reply
    Wu, Chun-Ying
    Hsu, Yao-Chun
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (08): : 766 - 767
  • [46] The preoperative positivity for serum hepatitis B e antigen did not affect overall survival after curative resection of hepatitis B virus-related hepatocellular carcinoma
    Choi, Gi Hong
    Kim, Dong Hyun
    Choi, Sae Byeol
    Kang, Chang Moo
    Kim, Kyung Sik
    Choi, Jin Sub
    Lee, Woo Jung
    Han, Kwang Hyub
    Chon, Chae Yoon
    Kim, Byong Ro
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 24 (03) : 391 - 398
  • [47] Impact of Antiviral Therapy on the Survival of Patients After Major Hepatectomy for Hepatitis B Virus-Related Hepatocellular Carcinoma
    Chan, Albert C. Y.
    Chok, Kenneth S. H.
    Yuen, Wai Key
    Chan, See Ching
    Poon, Ronnie T. P.
    Lo, Chung Mau
    Fan, Sheung Tat
    ARCHIVES OF SURGERY, 2011, 146 (06) : 675 - 681
  • [48] A scoring model combining serum alpha-fetoprotein and tumor size and number predicts prognosis in hepatitis B virus-related hepatocellular carcinoma patients after curative hepatectomy
    Wei, Bai
    Chen, Jing-San
    Yang, Sheng-Li
    Chen, George G.
    He, Hao
    TRANSLATIONAL CANCER RESEARCH, 2019, 8 (04) : 1438 - 1448
  • [49] Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial
    Pan, Li-Xin
    Wang, Yi-Yang
    Li, Zhong-Hai
    Luo, Jia-Xi
    Wu, Kun-Jun
    Liu, Zhen-Xiu
    Wu, Pei-Sheng
    Chen, Kang
    Ma, Liang
    Fan, Xiao-Hui
    Zhong, Jian-Hong
    TRIALS, 2024, 25 (01)
  • [50] Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial
    Li-Xin Pan
    Yi-Yang Wang
    Zhong-Hai Li
    Jia-Xi Luo
    Kun-Jun Wu
    Zhen-Xiu Liu
    Pei-Sheng Wu
    Kang Chen
    Liang Ma
    Xiao-Hui Fan
    Jian-Hong Zhong
    Trials, 25
12345